These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26531247)

  • 21. Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
    Yamada K; Noguchi K; Komeno T; Furuta Y; Nishizono A
    J Infect Dis; 2016 Apr; 213(8):1253-61. PubMed ID: 26655300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection.
    Geng J; Ren N; Yang C; Wang F; Huang D; Rodriguez S; Yuan Z; Xia H
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675972
    [No Abstract]   [Full Text] [Related]  

  • 23. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.
    Shiraki K; Daikoku T
    Pharmacol Ther; 2020 May; 209():107512. PubMed ID: 32097670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.
    Pascua PNQ; Marathe BM; Vogel P; Webby RJ; Govorkova EA
    J Antimicrob Chemother; 2019 May; 74(5):1333-1341. PubMed ID: 30715325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ebola virus dynamics in mice treated with favipiravir.
    Madelain V; Oestereich L; Graw F; Nguyen TH; de Lamballerie X; Mentré F; Günther S; Guedj J
    Antiviral Res; 2015 Nov; 123():70-7. PubMed ID: 26343011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys.
    Jahrling PB; Peters CJ; Stephen EL
    J Infect Dis; 1984 Mar; 149(3):420-7. PubMed ID: 6715898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration.
    Tani H; Komeno T; Fukuma A; Fukushi S; Taniguchi S; Shimojima M; Uda A; Morikawa S; Nakajima N; Furuta Y; Saijo M
    PLoS One; 2018; 13(10):e0206416. PubMed ID: 30365543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
    PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
    McElroy AK; Akondy RS; Harmon JR; Ellebedy AH; Cannon D; Klena JD; Sidney J; Sette A; Mehta AK; Kraft CS; Lyon MG; Varkey JB; Ribner BS; Nichol ST; Spiropoulou CF
    J Infect Dis; 2017 Jun; 215(12):1862-1872. PubMed ID: 28863472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
    Gowen BB; Smee DF; Wong MH; Hall JO; Jung KH; Bailey KW; Stevens JR; Furuta Y; Morrey JD
    PLoS One; 2008; 3(11):e3725. PubMed ID: 19008960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    Gowen BB; Juelich TL; Sefing EJ; Brasel T; Smith JK; Zhang L; Tigabu B; Hill TE; Yun T; Pietzsch C; Furuta Y; Freiberg AN
    PLoS Negl Trop Dis; 2013; 7(12):e2614. PubMed ID: 24386500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A man with fatal Lassa fever following a stay in Sierra Leone].
    Veldkamp PJ; Schippers EF
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2201-4. PubMed ID: 12467165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The therapeutic efficacy of ribamidil and virazole in experimental Lassa fever in monkeys].
    Dvoretskaia VI; Bogatikov GV; Pshenichnov VA; Evseev AA
    Vopr Virusol; 1991; 36(1):55-7. PubMed ID: 1858356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lassa fever and ribavirin].
    Bourée P
    Med Sante Trop; 2015; 25(2):130. PubMed ID: 26425737
    [No Abstract]   [Full Text] [Related]  

  • 35. Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections.
    Okogbenin S; Erameh C; Okoeguale J; Edeawe O; Ekuaze E; Iraoyah K; Agho J; Groger M; Kreuels B; Oestereich L; Babatunde FO; Akhideno P; Günther S; Ramharter M; Omansen T
    Emerg Infect Dis; 2022 Oct; 28(10):2060-2063. PubMed ID: 36148915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides.
    Sempere RN; Arias A
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of clinical and laboratory data in two cases of imported Lassa fever.
    Schmitz H; Köhler B; Laue T; Drosten C; Veldkamp PJ; Günther S; Emmerich P; Geisen HP; Fleischer K; Beersma MF; Hoerauf A
    Microbes Infect; 2002 Jan; 4(1):43-50. PubMed ID: 11825774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virus.
    Kato H; Takayama-Ito M; Satoh M; Kawahara M; Kitaura S; Yoshikawa T; Fukushi S; Nakajima N; Komeno T; Furuta Y; Saijo M
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009553. PubMed ID: 34214091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Julander JG; Furuta Y; Shafer K; Sidwell RW
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.